Ameren Corporation AEE
Set alert
111.37 USD +0.82 +0.75%
As of Nov 2, 1:55 PM ET
110.06 Day range 111.42
97.25 52-week range 118.32
- YTD
- +11.52%
- 1 year
- +9.16%
- Open
- 110.38
- Prev close
- 110.54
- Mkt cap
- 30.83B
- Vol
- 444.51K
- Avg vol
- 1.71M
- EPS
- 5.68
- P/E
- 19.61
- Div yield
- 2.72%
More statistics
- Low
- 110.06
- High
- 111.42
- Forward P/E
- 19.05
- Beta
- 0.45
- Short ratio
- 7.44
- Inst. own
- 90.44%
- Dividend
- 3.00
- Ex-div date
- Dec 7, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 104.35
- 200-d avg
- 108.36
- 1y target
- 115.06
3M chart
Events in this range
- Sep 8, 2026Dividend: 0.75
- Oct 13, 2026Rating: Keybanc · Overweight → Overweight
- Oct 14, 2026Rating: Truist Securities · Buy → Buy
- Oct 19, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 20, 2026Rating: BMO Capital · Outperform → Outperform
- Oct 21, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Oct 22, 2026Rating: TD Cowen · — → Hold
Signals (13)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 2026 | 4 hours ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
Financial health
Altman Z-Score
0.92 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 1
- Return on Equity 4
- Return on Assets 3
- Debt / Equity 2
- P/E 2
- P/B 2
Valuation
P/E 18.6×
FY 2016 5y median 20.1× FY 2025
P/S 3.1×
FY 2016 5y median 3.1× FY 2025
P/B 2.0×
FY 2016 5y median 2.0× FY 2025
P/FCF -32.9×
FY 2016 5y median -15.8× FY 2025
EV/EBITDA 11.6×
FY 2016 5y median 12.0× FY 2025
EV/Sales 5.3×
FY 2016 5y median 5.3× FY 2025
FCF Yield -3.0%
FY 2016 5y median -6.3% FY 2025
Profitability
Gross Margin 29.6%
FY 2016 5y median 46.2% FY 2025
Operating Margin 23.0%
FY 2016 5y median 20.8% FY 2025
Net Margin 16.5%
FY 2016 5y median 15.5% FY 2025
ROE 10.9%
FY 2016 5y median 10.2% FY 2025
ROIC 4.0%
FY 2016 5y median 3.5% FY 2025
ROA 3.0%
FY 2016 5y median 2.8% FY 2025
Growth (YoY)
Revenue 15.4%
FY 2016 FY 2025
Operating Income 33.6%
FY 2016 FY 2025
EPS (diluted) 21.0%
FY 2016 FY 2025
Free Cash Flow 50.2%
FY 2016 FY 2025
Financial Health
Current Ratio 0.7×
FY 2016 5y median 0.7× FY 2025
Quick Ratio 0.5×
FY 2016 5y median 0.5× FY 2025
Debt / Equity 1.5×
FY 2016 5y median 1.5× FY 2025
Net Debt / EBITDA 4.9×
FY 2016 5y median 4.8× FY 2025
Interest Coverage 2.6×
FY 2016 5y median 2.8× FY 2025
Dividends
Dividend Yield 2.8%
FY 2016 5y median 2.8% FY 2025
Payout Ratio 52.7%
FY 2016 5y median 57.1% FY 2025
Annual · latest fiscal year ends 2025-12-31